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http://dx.doi.org/10.1016/j.ejcsup.2013.07.064Irving Taylor1. IntroductionIt is my pleasure to present, on behalf of the European Cancer
Organisation, the education book for the 2013 European Mul-
tidisciplinary Cancer Conference.
The comprehensive educational programme for the con-
ference has been developed as a result of the collaborative
work of both the scientific and educational committees of
ECCO.
Readers will note that the book covers a number of impor-
tant topics relating to common solid malignancies with the
overall theme of achieving an optimal approach and therefore
optimal results for our patients.
The topics covered are localised rectal cancer, early breast
cancer, resectable non-small-cell lung cancer, renal cancer
and melanoma. We have also included an extremely impor-
tant section on the mood disorders in cancer patients.
In each chapter relating to specific solid tumours, an ap-
proach to achieving optimal outcomes is discussed by a con-
sideration of the basic biological characteristics of the tumour
and its clinical management, as well as the integration of the
two. It is remarkable how similar the basic principles of man-
agement for each of the tumours are. For example, the impor-
tance of careful preoperative staging with modern imaging
and good, careful and fastidious surgical resection is crucial
and strongly emphasised. For this to be achieved, specialised
understanding of the biology of the tumour and its anatomi-
cal confines is essential. Accordingly surgical specialisation is
now amandatory requisite since outcome correlates with vol-
ume of patients treated.The importance of a careful pathological examination is
emphasised, not only to determine prognosis but also to
determine the most effective adjuvant and in some cases,
neoadjuvant treatment that is required.
There is increasing emphasis on personalised treatment
determined by biological variables, and this is also empha-
sised in each chapter. In addition, the morbidity and indeed
mortality associated with the specific modalities of treatment
are documented so that risk–benefit analyses can be
assessed.
As clinicians, we must not ignore the importance of eco-
nomic consequences and resource implications of treat-
ments, and this societal concern is also discussed. Finally,
the importance of an integrated multidisciplinary approach
to the management of these tumours is emphasised by all
authors.
The authors of each chapter are to be congratulated for
providing excellent up-to-date reviews backed by detailed
and comprehensive lists of key references which include all
the major randomised clinical trials and meta-analyses for
the particular malignancy. Readers will find this particularly
useful in determining their decision-making.
I would like to thank all our authors and Chairs for their
hard work in providing chapters for this educational book,
and I hope our readers find their efforts worthwhile. I am par-
ticularly grateful to Samira Essiaf for her invaluable expertise
in preparing the book and dealing with all the administration.
I do hope you find the chapters helpful and of educational
benefit and enjoy reading them as much as I enjoyed editing
them.
